Curbline Properties CURB 深 沪
等待开盘 10-30 09:30:00 美东时间
28.73
+0.680
+2.42%
华盛通- 最 高29.125
- 今 开28.50
- 成交量 102.13万股
- 最 低 28.34
- 昨 收 28.05
- 总市值 34.89亿
- 52周最高 31.98
- 市盈率 静 77.02
- 换手率 0.84%
- 52周最低 21.63
- 委 比 -42.86%
- 总股本 1.21亿
- 历史最高 31.98
- 量 比 0.58
- 振 幅 2.80%
- 历史最低 18.73
- 每 手 1
- 风险率 2.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Curbline Properties shares are trading higher after the company reported strong Q3 operating FFO and raised its FY operating FFO guidance, citing a growing Signed Not Opened pipeline and continued investment activity.
Curbline Properties shares are trading higher after the company reported strong Q3 operating FFO and raised its FY operating FFO guidance, citing a growing Signed Not Opened pipeline and continued investment activity.
10-23 01:31
Curbline Properties Raises FY2026 FFO Guidance from $1.24-$1.26 to $1.25-$1.27 vs $1.25 Est
Curbline Properties (NYSE:CURB) raises FY2026 FFO guidance from $1.24-$1.26 to $1.25-$1.27 vs $1.25 analyst estimate..
10-22 18:31
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
Piper Sandler Maintains Overweight on Curbline Properties, Lowers Price Target to $38
Piper Sandler analyst Alex Goldfarb maintains Curbline Properties (NYSE:CURB) with a Overweight and lowers the price target from $39 to $38.
10-12 22:50
美股大行评级 | 潜在涨幅405.62%！Inventiva(IVA)获Truist Securities上调目标价至18美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持Inventiva"买入"评级，目标价从13美元升至18美元；富瑞：维持Sagimet Biosciences"买入"评级，目标价从25美元升至26美元
10-05 16:26
Truist Securities Assumes Curbline Properties at Buy, Raises Price Target to $33
Truist Securities analyst Linda Tsai assumes Curbline Properties (NYSE:CURB) with a Buy rating and raises Price Target to $33.
10-03 00:12
Curbline Properties Corp. declares $0.17 dividend
Curbline Properties Corp. (CURB) declares $0.17/share quarterly dividend, in line with previous. Forward yield 2.37% Payable Oct. 14; for shareholders of record Sept. 29; ex-div Sept. 29. See CURB Div...
09-17 06:03
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
Jefferies Initiates Coverage On Curbline Properties with Buy Rating, Announces Price Target of $36
Jefferies analyst Jonathan Petersen initiates coverage on Curbline Properties (NYSE:CURB) with a Buy rating and announces Price Target of $36.
08-25 23:03
